175 related articles for article (PubMed ID: 30828495)
1. Tumor mutational profile of triple negative breast cancer patients in Thailand revealed distinctive genetic alteration in chromatin remodeling gene.
Niyomnaitham S; Parinyanitikul N; Roothumnong E; Jinda W; Samarnthai N; Atikankul T; Suktitipat B; Thongnoppakhun W; Limwongse C; Pithukpakorn M
PeerJ; 2019; 7():e6501. PubMed ID: 30828495
[TBL] [Abstract][Full Text] [Related]
2. Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences.
Serio PAMP; de Lima Pereira GF; Katayama MLH; Roela RA; Maistro S; Folgueira MAAK
Cells; 2021 Dec; 10(12):. PubMed ID: 34944094
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419.
Routh ED; Van Swearingen AED; Sambade MJ; Vensko S; McClure MB; Woodcock MG; Chai S; Cuaboy LA; Wheless A; Garrett A; Carey LA; Hoyle AP; Parker JS; Vincent BG; Anders CK
Front Oncol; 2022; 12():818693. PubMed ID: 35992833
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer.
Hercules SM; Liu X; Bassey-Archibong BBI; Skeete DHA; Smith Connell S; Daramola A; Banjo AA; Ebughe G; Agan T; Ekanem IO; Udosen J; Obiorah C; Ojule AC; Misauno MA; Dauda AM; Egbujo EC; Hercules JC; Ansari A; Brain I; MacColl C; Xu Y; Jin Y; Chang S; Carpten JD; Bédard A; Pond GR; Blenman KRM; Manojlovic Z; Daniel JM
Cancer Causes Control; 2022 Jun; 33(6):831-841. PubMed ID: 35384527
[TBL] [Abstract][Full Text] [Related]
5. Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers.
Kaur J; Chandrashekar DS; Varga Z; Sobottka B; Janssen E; Gandhi K; Kowalski J; Kiraz U; Varambally S; Aneja R
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761830
[TBL] [Abstract][Full Text] [Related]
6. Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations.
Guerini-Rocco E; Piscuoglio S; Ng CK; Geyer FC; De Filippo MR; Eberle CA; Akram M; Fusco N; Ichihara S; Sakr RA; Yatabe Y; Vincent-Salomon A; Rakha EA; Ellis IO; Wen YH; Weigelt B; Schnitt SJ; Reis-Filho JS
J Pathol; 2016 Apr; 238(5):677-88. PubMed ID: 26806567
[TBL] [Abstract][Full Text] [Related]
7. The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study.
Guerini-Rocco E; Hodi Z; Piscuoglio S; Ng CK; Rakha EA; Schultheis AM; Marchiò C; da Cruz Paula A; De Filippo MR; Martelotto LG; De Mattos-Arruda L; Edelweiss M; Jungbluth AA; Fusco N; Norton L; Weigelt B; Ellis IO; Reis-Filho JS
J Pathol; 2015 Oct; 237(2):166-78. PubMed ID: 26011570
[TBL] [Abstract][Full Text] [Related]
8. Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.
Wang L; Zhai Q; Lu Q; Lee K; Zheng Q; Hong R; Wang S
Ann Med; 2021 Dec; 53(1):1358-1369. PubMed ID: 34396843
[TBL] [Abstract][Full Text] [Related]
9. Distinct Somatic Alteration Features Identified by Gene Panel Sequencing in Korean Triple-Negative Breast Cancer with High Ki67 Expression.
Sun WY; Lee J; Kim BK; Kim JO; Park J
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33804295
[TBL] [Abstract][Full Text] [Related]
10. Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer.
Toffoli S; Bar I; Abdel-Sater F; Delrée P; Hilbert P; Cavallin F; Moreau F; Van Criekinge W; Lacroix-Triki M; Campone M; Martin AL; Roché H; Machiels JP; Carrasco J; Canon JL
Breast Cancer Res; 2014 Nov; 16(6):466. PubMed ID: 25416589
[TBL] [Abstract][Full Text] [Related]
11. Molecular analyses of triple-negative breast cancer in the young and elderly.
Aine M; Boyaci C; Hartman J; Häkkinen J; Mitra S; Campos AB; Nimeus E; Ehinger A; Vallon-Christersson J; Borg Å; Staaf J
Breast Cancer Res; 2021 Feb; 23(1):20. PubMed ID: 33568222
[TBL] [Abstract][Full Text] [Related]
12. Mutational Analysis of Triple-Negative Breast Cancer Using Targeted Kinome Sequencing.
Yoo TK; Lee WS; Kim J; Kim MK; Park IA; Kim JH; Han W
J Breast Cancer; 2022 Jun; 25(3):164-177. PubMed ID: 35657000
[TBL] [Abstract][Full Text] [Related]
13.
Jouali F; El Ansari FZ; Marchoudi N; Barakat A; Zmaimita H; Samlali H; Fekkak J
Int J Mol Epidemiol Genet; 2020; 11(1):16-25. PubMed ID: 32714499
[TBL] [Abstract][Full Text] [Related]
14. Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy.
Darb-Esfahani S; Denkert C; Stenzinger A; Salat C; Sinn B; Schem C; Endris V; Klare P; Schmitt W; Blohmer JU; Weichert W; Möbs M; Tesch H; Kümmel S; Sinn P; Jackisch C; Dietel M; Reimer T; Loi S; Untch M; von Minckwitz G; Nekljudova V; Loibl S
Oncotarget; 2016 Oct; 7(42):67686-67698. PubMed ID: 27611952
[TBL] [Abstract][Full Text] [Related]
15. Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.
Zhang G; Wang Y; Chen B; Guo L; Cao L; Ren C; Wen L; Li K; Jia M; Li C; Mok H; Chen X; Wei G; Lin J; Zhang Z; Hou T; Han-Zhang H; Liu C; Liu H; Liu J; Balch CM; Meric-Bernstam F; Liao N
Ann Transl Med; 2019 Apr; 7(8):179. PubMed ID: 31168460
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern.
Li YZ; Chen B; Lin XY; Zhang GC; Lai JG; Li C; Lin JL; Guo LP; Xiao WK; Mok H; Ren CY; Wen LZ; Cao FR; Lin X; Qi XF; Liu Y; Liao N
Front Oncol; 2022; 12():830124. PubMed ID: 35402236
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers.
Castaneda CA; Lopez-Ilasaca M; Pinto JA; Chirinos-Arias M; Doimi F; Neciosup SP; Rojas KI; Vidaurre T; Balko JM; Arteaga CL; Gomez HL
Hematol Oncol Stem Cell Ther; 2014 Dec; 7(4):142-8. PubMed ID: 25467032
[TBL] [Abstract][Full Text] [Related]
18. Association between tumor mutation profile and clinical outcomes among Hispanic Latina women with triple-negative breast cancer.
Philipovskiy A; Dwivedi AK; Gamez R; McCallum R; Mukherjee D; Nahleh Z; Aguilera RJ; Gaur S
PLoS One; 2020; 15(9):e0238262. PubMed ID: 32886682
[TBL] [Abstract][Full Text] [Related]
19. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Liang X; Vacher S; Boulai A; Bernard V; Baulande S; Bohec M; Bièche I; Lerebours F; Callens C
Breast Cancer Res; 2018 Aug; 20(1):88. PubMed ID: 30086764
[TBL] [Abstract][Full Text] [Related]
20. Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategies.
Ma D; Jiang YZ; Xiao Y; Xie MD; Zhao S; Jin X; Xu XE; Shao ZM
Cancer; 2020 Jul; 126(14):3209-3218. PubMed ID: 32383785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
